Vital Signs - Needles in a Haystack - The Search for Protein Biomarkers

 

Regular Price: USD 1,500.00

Special Price USD 1,050.00

30% OFF

* Required Fields

Regular Price: USD 1,500.00

Special Price USD 1,050.00

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on February 19, 2007, provides a strategic overview of the importance of healthcare industry collaboration for biomarker identification and clinical use. Additionally, an emerging company profile is provided for BioMarker Pharmaceuticals, a company focused on exploiting genetic differences to combat aging and obesity-related diseases. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of February 5 - February 9, 2007.

Table of Contents

Vital Signs - Needles in a Haystack - The Search for Protein BiomarkersVital Signs: 19 February 2007This week's issue:




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.